Torrent Pharmaceuticals Ltd
Fortune 500 2024
+ 14 More
+ 14 More
Share
Share
OVERVIEW
FINANCIALS
NEWS
About
The Torrent Group was founded by Late Mr. U. N. Mehta in 1959 and is currently lead by Mr. Sudhir Mehta and Mr. Samir Mehta. Torrent Pharma, the flagship company of the Group is one of the leading pharma companies of the country. The establishment was a pioneer in initiating the concept of niche marketing in India and today is ranked amongst the leaders in therapeutic segment of cardiovascular, central nervous system, gastro-intestinal and women healthcare. Torrent Pharma forayed into Germany in 2005 with the acquisition of Heumann Generics, a Pfizer Group company . The company also has a strong international presence spread across 50 countries with operations in the US, Europe, and rest of the world.
Incorporation Year: 1972
Headquarters: Ahemdabad, Gujarat
Top Management: Sudhir & Samir Mehta
Industry: Pharma
Website: www.torrentpharma.com
Featured In Fortune India Ranking
Fortune 500 India
#220(2024)
#222(2023)
#209(2022)
#177(2021)
#177(2020)
#194(2019)
#206(2018)
#205(2017)
#188(2016)
#229(2015)
#245(2014)
#277(2013)
#315(2012)
#309(2011)
#308(2010)
#220(2024)#222(2023)#209(2022)#177(2021)#177(2020)#194(2019)#206(2018)#205(2017)#188(2016)#229(2015)#245(2014)#277(2013)#315(2012)#309(2011)#308(2010)
Ranking Trend Fortune 500 India
Financial Data 2024
Revenue
11,029
(INR Cr)
Net Operating Income
10,728
(INR Cr)
Assets
11,333
(INR Cr)
Profit
1,656
(INR Cr)
Net Worth
6,856
(INR Cr)
Fortune India Coverage
Read More
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 11029 16.1% | 9499 10.1% | 8631 3.5% | 8341 1.8% | 8194 7.2% | 7646 15.7% | 6611 7.0% | 6179 -12.5% | 7060 41.2% | 5000 16.9% | 4276 23.3% | 3468 26.4% | 2744 15.3% | 2380 21.5% | 1959 16.8% | 1677 - |
| Net Operating Income (INR Cr) | 10728 11.51% | 9620 13.07% | 8508 6.29% | 8005 0.82% | 7939 3.47% | 7673 28.96% | 5950 2.31% | 5816 -13.03% | 6687 43.70% | 4653 11.20% | 4185 30.32% | 3211 19.11% | 2696 22.66% | 2198 16.31% | 1890 17.15% | 1613 20.06% |
| Profit (INR Cr) | 1656 33.0% | 1245 60.2% | 777 -37.9% | 1252 22.2% | 1025 134.9% | 436 -35.7% | 678 -27.4% | 934 -46.1% | 1733 130.8% | 751 13.1% | 664 53.4% | 433 52.4% | 284 5.1% | 270 16.9% | 231 25.4% | 184 - |
| Assets (INR Cr) | 11333 -5.4% | 11982 15.2% | 10401 -6.3% | 11094 0.3% | 11065 -0.1% | 11073 -2.8% | 11392 59.7% | 7132 16.9% | 6102 12.0% | 5446 68.4% | 3235 43.5% | 2255 19.3% | 1890 14.4% | 1653 22.1% | 1353 19.4% | 1133 - |
| Net Worth (INR Cr) | 6856 10.6% | 6198 4.1% | 5953 2.0% | 5837 21.0% | 4823 2.1% | 4724 2.2% | 4622 6.3% | 4350 24.5% | 3494 40.3% | 2491 30.9% | 1902 33.8% | 1422 19.1% | 1194 16.8% | 1022 23.0% | 831 27.7% | 651 27.7% |
| Employee Cost (INR Cr) | 1984 18.3% | 1678 9.9% | 1526 6.0% | 1440 0.7% | 1429 1.8% | 1404 23.7% | 1135 14.3% | 993 17.9% | 842 0.1% | 842 13.6% | 741 18.9% | 623 17.2% | 532 20.7% | 440 39.3% | 316 23.3% | 256 - |
| Interest Cost (INR Cr) | 354 | 333 | 255 | 353 | 451 | 504 | 308 | 206 | 184 | 175 | 59 | 34 | 39 | 39 | 29 | 39 |
| Cash & Bank Balance (INR Cr) | 839 | 571 | 403 | 604 | 667 | 816 | 867 | 894 | 647 | 567 | 769 | 627 | 674 | 479 | 388 | 230 |
| Total Debt (INR Cr) | 4022 | 5369 | 4070 | 4874 | 5784 | 6038 | 6462 | 2510 | 2352 | 2740 | 1132 | 693 | 579 | 572 | 522 | 483 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 15.0% | 13.1% | 9.0% | 15.0% | 12.5% | 5.7% | 10.3% | 15.1% | 24.6% | 15.0% | 15.5% | 12.5% | 10.4% | 11.4% | 11.8% | 11.0% |
| Profit As % Of Assets | 14.6% | 10.4% | 7.5% | 11.3% | 9.3% | 3.9% | 6.0% | 13.1% | 28.4% | 13.8% | 20.5% | 19.2% | 15.0% | 16.4% | 17.1% | 16.3% |
| Profit As % Of Networth | 24.2% | 20.1% | 13.1% | 21.5% | 21.3% | 9.2% | 14.7% | 21.5% | 49.6% | 30.2% | 34.9% | 30.4% | 23.8% | 26.4% | 27.8% | 28.3% |
| Interest Cost to EBITDA % | 10.5% | 11.7% | 13.1% | 14.2% | 20.8% | 31.0% | 22.9% | 14.9% | 7.3% | 17.2% | 6.2% | 5.2% | 9.1% | 10.1% | 7.4% | 17.1% |
| Debt to Equity Ratio | 0.59 | 0.87 | 0.68 | 0.84 | 1.20 | 1.28 | 1.40 | 0.58 | 0.67 | 1.10 | 0.59 | 0.49 | 0.48 | 0.56 | 0.63 | 0.74 |
| RONW | 25.4% | 20.5% | 18.3% | 23.5% | 21.5% | 12.8% | 15.1% | 23.8% | 57.9% | 34.2% | 39.9% | 33.2% | 29.8% | 29.1% | 31.2% | 31.8% |
| ROCE | 23.2% | 19.5% | 18.2% | 17.0% | 14.8% | 12.3% | 13.4% | 19.6% | 43.8% | 25.7% | 32.9% | 29.7% | 25.6% | 25.4% | 30.3% | 23.1% |